INEGY

This brand name is authorized in Austria, Cyprus, Germany, Spain, France, Croatia, Ireland, Italy, Netherlands, Poland, United Kingdom, South Africa

Active ingredients

The drug INEGY contains a combination of these active pharmaceutical ingredients (APIs):

1 Ezetimibe UNII EOR26LQQ24 - EZETIMIBE

Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol. Read about Ezetimibe

2 Simvastatin UNII AGG2FN16EV - SIMVASTATIN

Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations. Read about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INEGY Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10BA02	Simvastatin and ezetimibe	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00140296, 00760946, 00760975, 00761029, 00761041, 00761064, 00761093, 00761118, 00761130, 05374136, 06766648, 06766677, 06766714, 07495393, 07758881, 07758906, 07758912, 07758958, 09607092, 09607100, 09649328, 09887335, 09887341, 09887358, 10135592, 10218450, 10263746, 10554751, 11022370, 11111151, 11111168, 11229450, 11282964, 11522316, 11522322, 11522339, 11522345, 11522351, 11522368, 11689944, 11689950, 11711201, 11711218, 11714145, 11714151, 12405311, 13845911, 14418217, 14418223, 14418513, 15293315, 15293321, 16735815, 16812243, 16812266, 17242440, 17242457, 17258346
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 66513, 66514, PA1286-062
Country: FR	Base de données publique des médicaments	Identifier(s): 60061709, 60371679, 61238347, 63857227, 65057814, 65722573
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 398364, 93100, 93104, 93108
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-251011951, HR-H-435536175, HR-H-814412843
Country: IE	Health Products Regulatory Authority	Identifier(s): 19562, 19635, 29803, 29845, 29869, 29876
Country: IT	Agenzia del Farmaco	Identifier(s): 036679064, 036679215, 036679367
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 77038, 77046, 77054
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100172614, 100172650, 100172689, 100172695
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/7.5/0031, A39/7.5/0032, A39/7.5/0033, A39/7.5/0034